Clonidine accumulation in human neuronal cells

Eur J Pharm Sci. 2007 Dec;32(4-5):291-5. doi: 10.1016/j.ejps.2007.08.004. Epub 2007 Aug 10.

Abstract

After transport across several epithelial barriers including the blood-brain barrier, clonidine interacts with alpha(2)-adrenergic receptors and imidazoline binding sites in the brain. We hypothesized that neuronal cells take up clonidine thereby removing the drug from the extracellular fluid compartment. Uptake of [(3)H]clonidine into SH-SY5Y neuroblastoma cells was linear for up to 1 min, unaffected by inside directed Na(+) or Cl(-) gradients but strongly inhibited by an outside pH of 6.0. The cells accumulated [(3)H]clonidine 50-70-fold uphill against a concentration gradient. Unlabeled clonidine, guanabenz, imipramine, diphenhydramine, maprotiline, quinine and the endogenous monoamine phenylethylamine (2 mM) strongly inhibited the [(3)H]clonidine uptake by 60-95%. Tetraethylammonium, choline and N-methyl-4-phenylpyridinium had no effect. The accumulation at pH 7.5 was saturable with an apparent Michaelis-Menten constant (K(t)) of 0.7 mM. We conclude that SH-SY5Y cells not only bind clonidine to extracellular receptors but also take up the drug rapidly by a specific and concentrative mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport / drug effects
  • Cells, Cultured
  • Clonidine / metabolism*
  • Clonidine / pharmacokinetics
  • Humans
  • Hydrogen-Ion Concentration
  • Kinetics
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Time Factors
  • Tritium / metabolism
  • Tritium / pharmacokinetics

Substances

  • Tritium
  • Clonidine